Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 pilot study of Deligoparin in recent-onset retinal vein occlusion
2005-003374-24Phase 2Completed
- Sponsor
- Opocrin SpA
- Start
- Aug 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of deligoparin in Vein occlusion (RVO) (2 arms), sponsored by Opocrin SpA. Started Aug 2005; status: completed.
02
Drugs
deligoparin
03
Conditions
Vein occlusion (RVO)
Beyond the preview
Go deeper on 2005-003374-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003374-24.